Directorate Changes RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world s leading long-term implantable biostable polymer (Elast-Eon
TM), is pleased to announce the appointments, with immediate effect, to the Board of Dr Caroline Stretton, Group Chief Operating Officer of the Company, and Ian Ardill as a Non-Executive Director and Chair of the Audit Committee. Dr Caroline Stretton who was appointed as Group Chief Operating Officer on 1 April 2020, following the Company s acquisition of RUA Medical Devices Limited ( RUA Medical ), joined RUA Medical in 2018 from prosthetic hand manufacturer, Touch Bionics Limited, where, prior to its sale in 2016 to Icelandic orthotic and prosthetic manufacturer Ossur, she was a key member of the leadership team responsible for Global Manufacturing, Operations, Quality and Customer Support. Previously, Caroline had been employed by a number of medical d